Insulin signaling pathways regulating PKCBeta splicing

调节 PKCβ 剪接的胰岛素信号通路

基本信息

  • 批准号:
    6914129
  • 负责人:
  • 金额:
    $ 1.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-08-15 至 2006-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION(provided by applicant): Insulin responsiveness in muscle, fat, and liver occurs via a complex network of signaling pathways that regulate metabolic processes including protein synthesis, glycogen synthesis, and glucose uptake. We reported that insulin rapidly regulated splicing of the pre-mRNA for PKCbetaII by enhanced exon inclusion. PKCBetaII and its alternatively spliced product, PKCBetaI, are involved in insulin signaling and have distinct functions in signaling pathways. Insulin regulation of alternative splicing occurs via activation of phosphatidylinositol 3-kinase (PI3-kinase) and possibly Akt and cPKC. Both kinases fulfill numerous roles in insulin signaling including nuclear actions. The splicing of PKCBetaII mRNA requires serine/arginine rich (SR) proteins that interact with the pre-mRNA to activate splice site selection for exon inclusion. We found that SRp40, one SR protein, is phosphorylated following insulin treatment in a P13-kinase dependent manner. Several kinases activated by P13-kinase and its products could phosphorylate SR proteins. The regulation of SR protein phosphorylation in relation to exon inclusion is a novel observation since phosphorylation of SR proteins by growth factor signaling pathways constitutes a new form of regulating splicing in addition to tissue specific- and developmental/cell cycle dependent- regulation. We hypothesize that Akt, PKC, and perhaps other kinases activated by PI3-kinase may phosphorylate SR proteins in response to insulin in skeletal muscle, fat and liver to regulate splice site selection. We will examine 1) the cis-elements identified by scanner linking mutagenesis of an insulin-responsive heterologous minigene we have developed to study exon inclusion (i.e., 216 bp exon encoding the C-terminal 52 amino acids of PKCBII and flanking intron sequences) in vivo in cell culture, 2) if SR proteins are substrates for Akt2 and cPKC isozymes, 3) the mechanism of splice site selection by developing in vitro splicing assays where HeLa cell nuclear extracts are supplemented with nuclear extracts from insulin-treated cells to track splicing intermediates, and 4) whether PKCBII alternative splicing can be redirected using antisense oliogonucleotides to probe functional elements in vivo. Elucidation of the signaling pathways that regulate splicing will become more important as an increasing number of proteins derived from alternative splicing are shown to have opposing effects on metabolic processes. The mechanism by which insulin regulates a process utilized to confer diversity in many biological systems represents a fundamental signaling event. The regulation of alternative splicing of PKCBetaII mRNA provides a molecular link between insulin activation of PI3-kinase and the post-transcriptional regulation of gene expression. The receptor signaling pathways involved in alternative pre-mRNA splicing may provide for a greater diversity in proteomic complexity than previously recognized.
描述(由申请人提供):肌肉、脂肪和 肝脏通过复杂的信号通路网络发生, 代谢过程,包括蛋白质合成、糖原合成和 葡萄糖摄取我们报道了胰岛素可以快速调节 通过增强的外显子包含来表达PKC β II的前体mRNA。PKCBetaII及其 选择性剪接产物PKC β I参与胰岛素信号传导, 在信号通路中有不同的功能。胰岛素调节 选择性剪接通过激活磷脂酰肌醇3-激酶而发生 (PI 3-激酶)和可能的Akt和cPKC。这两种激酶都在 胰岛素信号传导包括核作用。PKC β II mRNA的剪接 需要富含丝氨酸/精氨酸(SR)的蛋白质与前体mRNA相互作用, 激活剪接位点选择以包含外显子。我们发现SRp 40,一个SR 蛋白质,在胰岛素处理后在P13-激酶中被磷酸化 依赖的方式。P13-激酶及其产物激活的几种激酶 可以磷酸化SR蛋白。SR蛋白磷酸化的调控 与外显子包含有关是一个新的观察,因为 SR蛋白通过生长因子信号通路构成一种新的 除了组织特异性和发育/细胞外, 周期依赖-调节。我们假设Akt、PKC和其他可能的 由PI 3-激酶激活的激酶可响应于 胰岛素在骨骼肌、脂肪和肝脏中调节剪接位点选择。我们 将检查1)通过扫描仪连接诱变鉴定的顺式元件, 我们已经开发了一个胰岛素应答异源小基因, 包含(即,216 bp外显子编码PKCBII的C-末端52个氨基酸 和侧翼内含子序列),2)如果SR蛋白是 Akt 2和cPKC同工酶的底物,3)剪接位点的机制 通过开发体外剪接测定进行选择,其中HeLa细胞核 提取物补充有来自胰岛素处理的细胞的核提取物, 轨道剪接中间体,以及4)PKCB II选择性剪接是否可以 使用反义寡核苷酸重定向以探测 vivo.阐明调节剪接的信号通路将成为 更重要的是,越来越多的蛋白质来源于替代品, 剪接显示对代谢过程具有相反的影响。的 胰岛素调节用于赋予生物多样性的过程的机制。 许多生物系统代表了基本的信号事件。的 PKC β II mRNA可变剪接的调节提供了一种分子联系, 胰岛素对PI 3-激酶的激活与转录后 基因表达的调控。受体信号通路参与 选择性前mRNA剪接可以提供蛋白质组学的更大多样性, 比以前认识到的复杂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENISE Ratzlaff COOPER其他文献

DENISE Ratzlaff COOPER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENISE Ratzlaff COOPER', 18)}}的其他基金

Mechanisms for treating ischemic wounds with human adipocyte derived stem cell exosomes
人脂肪细胞来源的干细胞外泌体治疗缺血性伤口的机制
  • 批准号:
    9349163
  • 财政年份:
    2017
  • 资助金额:
    $ 1.39万
  • 项目类别:
Mechanisms for treating ischemic wounds with human adipocyte derived stem cell exosomes
人脂肪细胞来源的干细胞外泌体治疗缺血性伤口的机制
  • 批准号:
    9898296
  • 财政年份:
    2017
  • 资助金额:
    $ 1.39万
  • 项目类别:
Insulin Signaling Pathways Regulating PKCBeta Splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    8012334
  • 财政年份:
    2010
  • 资助金额:
    $ 1.39万
  • 项目类别:
Insulin signaling pathways regulating PKCBeta splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    6704151
  • 财政年份:
    2001
  • 资助金额:
    $ 1.39万
  • 项目类别:
Insulin Signaling Pathways Regulating PKCBeta Splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    7778227
  • 财政年份:
    2001
  • 资助金额:
    $ 1.39万
  • 项目类别:
Insulin Signaling Pathways Regulating PKCBeta Splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    7466756
  • 财政年份:
    2001
  • 资助金额:
    $ 1.39万
  • 项目类别:
Insulin Signaling Pathways Regulating PKCBeta Splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    7871748
  • 财政年份:
    2001
  • 资助金额:
    $ 1.39万
  • 项目类别:
Insulin signaling pathways regulating PKCBeta splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    6792651
  • 财政年份:
    2001
  • 资助金额:
    $ 1.39万
  • 项目类别:
Insulin signaling pathways regulating PKC beta splicing
调节 PKC β 剪接的胰岛素信号通路
  • 批准号:
    6382861
  • 财政年份:
    2001
  • 资助金额:
    $ 1.39万
  • 项目类别:
Insulin signaling pathways regulating PKCBeta splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    6614449
  • 财政年份:
    2001
  • 资助金额:
    $ 1.39万
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    $ 1.39万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了